Importantly, in vitro experiments consisting in ETAR or ETBR blockade with selective antagonists or with the dual receptor antagonist bosentan (5) resulted in a significantly decreased viability of MM cell lines (8). The gene discussed is EDNRA; the disease is Miyoshi myopathy.